SCHEMBL4413285

SCHEMBL4413285

CCCCCCCCCCCCCCCCCc1cc(=O)oc2c(F)c(O)c(F)cc12

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 12/20 0.52
ALDH1A1 P00352 12/20 0.52
KDM4E B2RXH2 11/20 0.52
GLA P06280 9/20 0.52
HIF1A Q16665 9/20 0.52
HPGD P15428 7/20 0.52
CASP1 P29466 3/20 0.48
CASP7 P55210 3/20 0.48
HSD17B10 Q99714 3/20 0.48
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
ERAP1 Q9NZ08 2/20 0.46
ATM Q13315 1/20 0.46
HCAR2 Q8TDS4 2/20 0.41
MAPK1 P28482 1/20 0.40
EPAS1 Q99814 4/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL669385 0.78 MCL1 (0.56) GAAALDH1A1KDM4EGLAHIF1A
SCHEMBL875961 0.75 KDM4E (0.39) GAAALDH1A1KDM4EGLAHIF1A
SCHEMBL8564999 0.74 KDM4E (0.38) GAAALDH1A1KDM4EGLAHIF1A
SCHEMBL8565004 0.74 GAA (0.38) GAAALDH1A1KDM4EGLAHIF1A
SCHEMBL565580 0.73 MCL1 (0.55) GAAALDH1A1KDM4EGLAHPGD
SCHEMBL16096924 0.73 KMT2A (0.57) ALDH1A1KMT2AMEN1
SCHEMBL8571050 0.73 MET (0.51) GAAALDH1A1KDM4EHPGDHSD17B10
SCHEMBL18073952 0.72 KDM4E (0.52) GAAALDH1A1KDM4EGLAHIF1A
SCHEMBL15396964 0.72 ALDH1A1 (0.46) GAAALDH1A1KDM4EGLAHIF1A
SCHEMBL15170269 0.72 MCL1 (0.55) GAAALDH1A1KDM4EGLAHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1660638-B1 LIPOPARTICLES COMPRISING PROTEINS, METHODS OF MAKING, AND USING THE SAME INTEGRAL MOLECULAR INC (US) 2015-12-23 EP disclosed
US-9213027-B2 Lipoparticles comprising proteins, methods of making, and using the same INTEGRAL MOLECULAR, INC. (US) 2015-12-15 US disclosed
US-20140135230-A1 Lipoparticles Comprising Proteins, Methods Of Making, And Using The Same INTEGRAL MOLECULAR, INC. (US) 2014-05-15 US disclosed
US-8574590-B2 Lipoparticles comprising proteins, methods of making, and using the same INTEGRAL MOLECULAR, INC. (US) 2013-11-05 US disclosed
EP-1660638-A4 LIPOPARTICLES COMPRISING PROTEINS, METHODS OF MAKING, AND USING THE SAME INTEGRAL MOLECULAR INC (US) 2009-02-18 EP disclosed
EP-1660638-A2 LIPOPARTICLES COMPRISING PROTEINS, METHODS OF MAKING, AND USING THE SAME Integral Molecular, Inc. (US) 2006-05-31 EP disclosed
US-20050123563-A1 Lipoparticles comprising proteins, methods of making, and using the same NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2005-06-09 US disclosed
WO-2005042695-A2 LIPOPARTICLES COMPRISING PROTEINS, METHODS OF MAKING, AND USING THE SAME INTEGRAL MOLECULAR, INC. (US) 2005-05-12 WO disclosed
US-5830912-A Derivatives of 6,8-difluoro-7-hydroxycoumarin MOLECULAR PROBES, INC. (US) 1998-11-03 US disclosed